You just read:

FDA Accepts Supplemental New Drug Application for LONSURF® (trifluridine/tipiracil) for the Treatment of Metastatic Gastric/Gastroesophageal Junction (GEJ) Adenocarcinoma; Grants Priority Review

News provided by

Taiho Oncology, Inc.

Oct 25, 2018, 15:00 ET